{"id":"W4414163737","doi":"10.1016/j.jogc.2025.103107","title":"First-Line Treatment Use and Survival Outcomes for Patients With Primary Advanced or Recurrent Endometrial Cancer in Alberta, Canada","year":2025,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada); University of Alberta; University of Calgary; Alberta Health Services; Western University","funders":"Canadian Institutes of Health Research; Alberta Innovates; AstraZeneca; Women and Children's Health Research Institute; Children's Health Research Institute; GlaxoSmithKline","keywords":"Endometrial cancer; Overall survival; Primary treatment; Systemic therapy; Stage (stratigraphy); Primary (astronomy); Survival rate","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003204253,0.0001917364,0.0002938565,0.0007782569,0.00106326,0.0007635029,0.0008183998,0.0003336281,0.001738528],"category_scores_gemma":[0.001637757,0.000173425,0.0004184644,0.002357902,0.0004414625,0.0001942365,0.0004361242,0.0005085212,0.0001407585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01584594,"about_ca_system_score_gemma":0.01887663,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9816157,"about_ca_topic_score_gemma":0.9888192,"domain_scores_codex":[0.9994924,0.00003307046,0.00003029118,0.00006481659,0.0001779234,0.000201519],"domain_scores_gemma":[0.9986345,0.00007996064,0.0004530697,0.00003697213,0.0004367058,0.000358784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006573157,0.00001932536,0.9953411,0.00003230801,0.00004177838,0.0001005972,0.0001194845,0.0001281756,0.0000949223,0.00004035998,0.001027228,0.002989128],"study_design_scores_gemma":[0.00001609567,0.00002749966,0.9979188,0.00004301923,0.00003130361,0.0001879835,0.0004524725,0.0003076744,0.00004706907,0.00001872978,0.0009425411,0.000006815732],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98911,0.002432485,0.00009986354,0.0006860998,0.00002607532,0.00003600698,0.005121153,0.00001666832,0.002471747],"genre_scores_gemma":[0.9966874,0.0008216578,0.0001104551,0.000168027,0.00001236734,0.000009729617,0.001668441,0.000003474797,0.0005185634],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01838428,"threshold_uncertainty_score":0.1149709,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0185907389133937,"score_gpt":0.2719154014142532,"score_spread":0.2533246625008596,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}